Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.20
- Piotroski Score 7.00
- Grade Buy
- Symbol (CNMD)
- Company CONMED Corporation
- Price $71.92
- Changes Percentage (-3.8%)
- Change -$2.84
- Day Low $70.84
- Day High $76.25
- Year High $117.27
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
- Last Earnings 08/09/2024
- Ex-Dividend for 5/16 Dividend 09/16/2024
- Dividend Payable 10/04/2024
- Today N/A
- Next Earnings (Estimated) 10/22/2024
- Fiscal Year End N/A
- Average Stock Price Target $101.00
- High Stock Price Target $107.00
- Low Stock Price Target $95.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.61
- Trailing P/E Ratio 29.28
- Forward P/E Ratio 29.28
- P/E Growth 29.28
- Net Income $64.46 M
Income Statement
Quarterly
Annual
Latest News of CNMD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's What Key Metrics Tell Us About Conmed (CNMD) Q2 Earnings
Conmed's Q2 2024 revenue was $332.1 million, up 4.6% YoY, with EPS at $0.98. It fell slightly short of the consensus estimates....
By Yahoo! Finance | 1 month ago -
What Does CONMED Corporation's (NYSE:CNMD) Share Price Indicate?
CONMED Corporation has shown a promising 18% share price growth on the NYSE. Trading below industry average PE ratio, it presents a good investment opportunity with an expected 88% earnings increase. ...
By Yahoo! Finance | 2 months ago -
A Note On CONMED Corporation's (NYSE:CNMD) ROE and Debt To Equity
This article discusses how Return On Equity (ROE) can help evaluate a company's performance. It uses CONMED Corporation as an example, showing its ROE of 9.6% and debt to equity ratio of 1.16....
By Yahoo! Finance | 3 months ago
